spacer
home > ict > Spring 2018
PUBLICATIONS

International Clinical Trials

ict
Spring 2018

   
Text
PDF
Editor’s Comment
ICT's Editor Dr Graham Hughes introduces the key focus topics in these editions of ICT and EPC, highlighting a number of articles.
 
view
download pdf
bullet
REGULATORY
Clinical Trial Oversight Management

Perfecting Performance


When dealing with new revisions in the ICH  E6 (R2) guidelines, Gabriele Faist and Heike Schön at LUMIS International discuss how the implementation of keyperformance indicators could be beneficial.
 
view
download pdf
Regulation Changes

Clinical Navigation

With new developments in pharmacovigilance being continually implemented, Nick Barker and Katharine Colbert at Medpace express that sponsors andmarketing authorisation holders worldwide must ensure they are prepared
 
view
download pdf
bullet
Clinical Trial Management
Obstacles in Cancer Research

Essential Steps

Through a Q&A, Peter Langecker, Brian Travers, and Barb Geiger at Clinipace explain to ICT the intricacies that must be considered within oncological studies.

 
view
download pdf
Alzheimer’s Research

Improving Success Rates


Significant progress within clinical trials for Alzheimer’s is being made. Dr Michael F Murphy at Worldwide Clinical Trials says new trial designsare now addressing previous research challenges.
 
view
download pdf
Spotlight

York Health Economics Consortium


York Health Economics Consortium
is a health economics consulting company  owned by the University of York. It provides a range of services,including economic modelling, literature searching, systematic reviews,
network meta-analyses, outcomes research, and applied research and training to the NHS and the pharmaceutical and healthcare industries
 
view
download pdf
bullet
eCLINICAL
Oncology Trial Validity

Imaging Innovations


Working alongside effective site training, today's imaging analysis technology could bring improvements to the quality, timeline, and cost of oncology trials. Sophie Winandy at ERT explores how.
 
view
download pdf
eClinical Improvements

A New Pathway


Jeff Lee at Bracket details the ways in which technological approaches alongside unified thinking can enhance patient engagement, becominga key asset within clinical research.
 
view
download pdf
bullet
CLINICAL THERAPEUTICS
EMA First-in-Human Guidance

Exponential Developments


As regulations for first-in-human trials progress, Bradley Joblin at Q-Pharm examines the new considerationsthat must be made within early phase development.

 
view
download pdf
bullet
Trial Management & Outsourcing
The Sponsor/Vendor Relationship

Key Relations

Shanelle Mehta
at The Clinigen Group explores how outsourcing is becoming common practice within the pharmaceutical and biotechnology industries, thereby creating a good sponsor/vendor relationship and a reliable process.
 
view
download pdf

Business Practice
End Point

Public Perception


ICT Editor Dr Graham Hughes considers the role of clinical trials and how they are publicly perceived
 
view
download pdf

Cancer Therapeutics
Oncology Clinical Trials

Optimising Outcomes


Routine cancer care can be enhanced by integrating electronic patient-reported outcomes and clinical outcome assessments. Katie Garner at CRF Health examines how.
 
view
download pdf

Patient Recruitment and Retention
The Patient Experience

The Engagement Equation


Modern clinical trials rely on patient engagement. Aaron Fleishman and Sarah Mandracchia at BBK Worldwide analyse the new tools and techniques that must be utilised to ensure all trial stages are successful.

 
view
download pdf
bullet
Digital Advances
Digital and Cloud Developments

Revolution or Evolution?


As the industry begins to embrace new clinical methods, David Goldston at Veracity Logic considers how it disrupts conventional, long-standing trial management.
 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November

News and Press Releases

Kallik’s Release 6 sets new benchmarks for speed, accuracy and efficiency

Tamworth, UK – 15 June 2019 – Global provider of labelling and artwork management solutions, Kallik, is launching an update to its AMS360 solution – its Release 6, transforming the experience of the business user, whilst defining new benchmarks for speed, accuracy, and efficiency of global labelling and artwork processes.
More info >>

White Papers

Medpace Reference Laboratories establishes state of the art Flow Cytometry techniques for flexible approaches to clinical trials across multiple therapeutic areas.

Medpace

Cytometry is the process of measuring the properties of individual cells. These properties may include gene or protein expression, chemical properties, deoxyribonucleic acid (DNA) content, and various cellular functions. The earliest methods of cytometry relied upon light microscopy for the classification and observation of cells and cellular components. Microscopy permitted direct visual observation of cells for the first time, leading to the classification of cells by morphology and insight into cellular functions. However, the time required for microscopic analysis constrains the number of samples or number of cells in each sample that can be examined. Therefore, the utility of microscopy for analysis of rare cells or in situations where sample throughput is a priority is limited. Flow cytometry was developed largely to improve upon these limitations.
More info >>

Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement